John Johnson is Chief Executive Officer of Strongbridge Biopharma plc. Currently has a direct ownership of 0 shares of SBBP, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2021, when has been sold 610,092 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

JOHN JOHNSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2021
SELL
Sale (or disposition) back to the issuer
-
610,092 Reduced 100.0%
0 Ordinary Shares
Oct 01 2021
SELL
Payment of exercise price or tax liability
$689,828 $2.06 p/Share
334,868 Reduced 35.44%
610,092 Ordinary Shares
Jul 02 2021
SELL
Payment of exercise price or tax liability
$156,670 $3.08 p/Share
50,867 Reduced 5.11%
944,960 Ordinary Shares
Apr 08 2021
SELL
Payment of exercise price or tax liability
$46,431 $2.68 p/Share
17,325 Reduced 1.71%
995,827 Ordinary Shares
Jan 07 2021
BUY
Grant, award, or other acquisition
-
491,000 Added 32.64%
1,013,152 Ordinary Shares

Also insider at

AXGN
Axogen, Inc. Healthcare
VSTM
Verastem, Inc. Healthcare
XERS
Xeris Biopharma Holdings, Inc. Healthcare
JJ

John Johnson

Chief Executive Officer
Trevose, PA

Track Institutional and Insider Activities on SBBP

Follow Strongbridge Biopharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBBP shares.

Notify only if

Insider Trading

Get notified when an Strongbridge Biopharma PLC insider buys or sells SBBP shares.

Notify only if

News

Receive news related to Strongbridge Biopharma plc

Track Activities on SBBP